hydroxyurea has been researched along with Vitreoretinopathy, Proliferative in 1 studies
Vitreoretinopathy, Proliferative: Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Estepp, JH | 1 |
| Smeltzer, MP | 1 |
| Wang, WC | 1 |
| Hoehn, ME | 1 |
| Hankins, JS | 1 |
| Aygun, B | 1 |
1 other study available for hydroxyurea and Vitreoretinopathy, Proliferative
| Article | Year |
|---|---|
Protection from sickle cell retinopathy is associated with elevated HbF levels and hydroxycarbamide use in children.
Topics: Adolescent; Anemia, Sickle Cell; Antisickling Agents; Child; Drug Evaluation; Female; Fetal Hemoglob | 2013 |